Search Results - "Tabruyn, Sebastien P"
-
1
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Published in The Journal of clinical investigation (01-05-2013)“…Peripartum cardiomyopathy (PPCM) is a life-threatening pregnancy-associated cardiomyopathy in previously healthy women. Although PPCM is driven in part by the…”
Get full text
Journal Article Web Resource -
2
GATA2 is required for lymphatic vessel valve development and maintenance
Published in The Journal of clinical investigation (03-08-2015)“…Heterozygous germline mutations in the zinc finger transcription factor GATA2 have recently been shown to underlie a range of clinical phenotypes, including…”
Get full text
Journal Article -
3
Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors
Published in Cancer discovery (01-03-2012)“…Invasion and metastasis increase after the inhibition of VEGF signaling in some preclinical tumor models. In the present study we asked whether selective VEGF…”
Get more information
Journal Article -
4
Tobacco Alkaloid Assessment in a DSS-Induced Colitis Mouse Model with a Fully Humanized Immune System
Published in International journal of molecular sciences (29-03-2023)“…Inflammatory bowel disease (IBD) refers to chronic intestinal immune-mediated diseases including two main disease manifestations: ulcerative colitis (UC) and…”
Get full text
Journal Article -
5
Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways
Published in Biochemical pharmacology (15-06-2007)“…In cystic fibrosis (CF) patients, pulmonary inflammation is a major cause of morbidity and mortality and may precede bacterial colonization. The aim of the…”
Get full text
Journal Article Web Resource -
6
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD‐1 blockade
Published in Clinical and translational medicine (01-05-2024)“…Background Uterine leiomyosarcomas (uLMS) are aggressive tumours with poor prognosis and limited treatment options. Although immune checkpoint blockade (ICB)…”
Get full text
Journal Article -
7
The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation
Published in PloS one (07-11-2011)“…Angiogenesis, the formation of new blood vessels from existing vasculature, plays an essential role in tumor growth, invasion, and metastasis. 16K hPRL, the…”
Get full text
Journal Article Web Resource -
8
Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells
Published in Biochemical and biophysical research communications (11-05-2007)“…Cystic fibrosis is a common genetic disorder characterized by a severe lung inflammation and fibrosis leading to the patient’s death. Enhanced angiogenesis in…”
Get full text
Journal Article Web Resource -
9
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer
Published in Oncotarget (30-04-2015)“…The interaction between tumor cells and their microenvironment is an essential aspect of tumor development. Therefore, understanding how this microenvironment…”
Get full text
Journal Article Web Resource -
10
Prolactin/Growth Hormone-Derived Antiangiogenic Peptides Highlight a Potential Role of Tilted Peptides in Angiogenesis
Published in Proceedings of the National Academy of Sciences - PNAS (26-09-2006)“…Angiogenesis is a crucial step in many pathologies, including tumor growth and metastasis. Here, we show that tilted peptides exert antiangiogenic activity…”
Get full text
Journal Article Web Resource -
11
Molecular pathways of angiogenesis inhibition
Published in Biochemical and biophysical research communications (30-03-2007)“…A large body of evidence now demonstrates that angiostatic therapy represents a promising way to fight cancer. This research recently resulted in the approval…”
Get full text
Journal Article Web Resource -
12
NF-κB: a new player in angiostatic therapy
Published in Angiogenesis (London) (01-03-2008)“…Angiogenesis is considered a promising target in the treatment of cancer. Most of the angiogenesis inhibitors in late-stage clinical testing or approved for…”
Get full text
Journal Article Web Resource -
13
Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity
Published in Proceedings of the National Academy of Sciences - PNAS (01-11-2016)“…Therapeutic targeting of the VEGF signaling axis by the VEGF-neutralizing monoclonal antibody bevacizumab has clearly demonstrated clinical benefit in cancer…”
Get full text
Journal Article -
14
Angiopoietin-2-Driven Vascular Remodeling in Airway Inflammation
Published in The American journal of pathology (01-12-2010)“…Vascular remodeling is a feature of chronic inflammation during which capillaries transform into venules that expand the region of the vasculature in which…”
Get full text
Journal Article Web Resource -
15
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6 high uterine leiomyosarcoma to PD-1 blockade
Published in Clinical and translational medicine (01-05-2024)“…Uterine leiomyosarcomas (uLMS) are aggressive tumours with poor prognosis and limited treatment options. Although immune checkpoint blockade (ICB) has proven…”
Get full text
Journal Article -
16
Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors
Published in Cancer research (Chicago, Ill.) (15-05-2009)“…Vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and their receptors are important targets in cancer therapy based on…”
Get full text
Journal Article Web Resource -
17
Angiostatic activity of the antitumor cytokine interleukin-21
Published in Blood (15-12-2008)“…Interleukin-21 (IL-21) is a recently described immunoregulatory cytokine. It has been identified as a very potent immunotherapeutic agent in several cancer…”
Get full text
Journal Article Web Resource -
18
MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells
Published in Angiogenesis (London) (01-10-2013)“…Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by arteriovenous malformations and hemorrhages. This vascular…”
Get full text
Journal Article Web Resource -
19
The Angiostatic 16K Human Prolactin Overcomes Endothelial Cell Anergy and Promotes Leukocyte Infiltration via Nuclear Factor-κB Activation
Published in Molecular endocrinology (Baltimore, Md.) (01-06-2007)“…The 16-kDa N-terminal fragment of human prolactin (16K hPRL) is a potent angiostatic factor that inhibits tumor growth in mouse models. Using microarray…”
Get full text
Journal Article -
20
Angiopoietin/Tie2 Signaling Transforms Capillaries into Venules Primed for Leukocyte Trafficking in Airway Inflammation
Published in The American journal of pathology (01-04-2010)“…Vascular endothelial growth factor (VEGF) is a key angiogenic factor in tumors, but less is known about what drives vascular remodeling in inflammation, where…”
Get full text
Journal Article Web Resource